Instinct Bio Technical Company Holdings (BIOT) closed at $0.19 on November 12, 2026, down 7.3% from the previous close, on volume of 207,593 shares (30-day average 382,828).
Data as of November 12, 2026.
No headlines found.
Globe Newswire (Fri, 4-Sep 7:00 AM ET)
Instinct Bio Technical Company Holdings Inc is a Cayman Islands-based vertically integrated group engaged in the research and development, manufacturing, branding, and distribution of stem cells, regenerative medicine, wellness, and beauty as its core areas. Its product portfolio includes stem cell-derived serums and skincare formulations for aesthetic and dermatological applications. The company also develops regenerative products for skin healing, hydration, and elasticity.
Instinct Bio Technical Company Holdings trades on the NASDAQ stock market under the symbol BIOT.
As of November 12, 2026, BIOT stock price declined to $0.19 with 207,593 million shares trading.
BIOT has a beta of -10.69, meaning it tends to be less sensitive to market movements. BIOT has a correlation of 0.03 to the broad based SPY ETF.
BIOT has a market cap of $5.47 million. This is considered a Sub-Micro Cap stock.
BIOT support price is $.19 and resistance is $.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOT shares will trade within this expected range on the day.
